In a first, the US Food and Drug Administration (FDA) allowed the marketing of a new hearing aid that enables users to fit, programme and control it on their own, without assistance from a health care provider.
Nearly 40 million adults aged 18 and over report having some trouble hearing without a hearing aid, ranging from "a little trouble" to "deaf".
"Hearing loss is a significant public health issue, especially as individuals age," said Malvina Eydelman, Director at the FDA's Center for Devices and Radiological Health.
"Today's marketing authorisation provides certain patients with access to a new hearing aid that provides them with direct control over the fit and functionality of the device.
"The FDA is committed to ensuring that individuals with hearing loss have options for taking an active role in their health care," Eydelman added.
Hearing loss can be caused by ageing, exposure to loud noises, certain medical conditions and other factors. It may be permanent or temporary.
Individuals with permanent hearing loss can use hearing aids to help them hear the speech and sounds around them better, enabling them to communicate more effectively with others.
The Bose Hearing Aid is a user-fitted wireless air conduction hearing aid which works by capturing sound vibrations through one or more microphones.
In the hearing, the signal is processed, amplified and played back through an earphone placed in the ear canal. Patients can adjust the hearing aid through a mobile application on their phone.
This technology enables users to fit the hearing aid settings themselves, in real-time and in real-world environments without the assistance of a health care professional, the FDA said.
For authorising the marketing, the FDA reviewed data from clinical studies of 125 patients, it noted.
These demonstrated that outcomes with self-fitting of the Bose Hearing Aid are comparable on average to those with professional fitting of the same device with respect to the amount of amplification selected, speech in noise testing and overall benefit.
The Bose Hearing Aid has also been labelled to inform the consumer when to consult a hearing health care professional.
The FDA has granted the marketing authorisation of the Bose Hearing Aid device to Bose Corporation.
--IANS
rt/mag/vm
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
